Table 3.
Lipidopeptide/Protein | Lipid | Attachment Strategy | Effects | Ref. |
---|---|---|---|---|
Liraglutide | Palmitic acid | γ-glutamic acid | Extension of the half-life, reducing renal clearance | [171] |
Salmon calcitonin | N-palmitoylated | Cys-1 and Cys-7 of the peptide | Extension of the half-life, reducing renal clearance | [172] |
Opioid peptide leu-enkephalin | 3,4 bis(decylthiomethyl)- 2,5-furandione 16 |
N-terminus binding | Reducing receptor binding, increasing protease stability | [173] |
Thyrotropin-releasing hormone | lauric acid |
N-terminus binding | Peptide penetration across the small intestine |
[174,175] |
H-Ras | 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine | maleimide-functionalized phospholipids/ S-palmitoylation at Cys181 and Cys184 | Dimerization | [176] |
Caveolin-3 | octanethiol | cysteine S-fatty acylation | As a small protein model in the study of lipidation of proteins | [177] |
Interferon-induced transmembrane protein 3 (IFITM3) |
maleimide palmitate | maleimide-functionalized phospholipids/ S-palmitoylation at Cys72 and Cys105 | Enhancing the conserved amphipathic domain | [178] |
Cathepsin-B inhibitor | Palmitic acid | Palmitoylation of the amino groups (ε-lysyl amino groups) |
Increasing the inhibitory effect on cathepsin-B | [179] |